Adoption and Diffusion of Disruptive Technologies: The Case of Additive Manufacturing in MedTech
These stakeholders involve manufacturers, regulatory bodies, industry associations, insurers, researchers, surgeons and patients. Such exercises will be instrumental to collaboratively develop a roadmap for widespread adoption of 3D Printed implants and medical devises in general, which will benefit the industry as a whole.
Andrew Batty will facilitate the workshop.
During the morning, there will be six panelists representing various stakeholders including manufacturers, regulatory bodies, industry associations, insurers, researchers, surgeons, and patients. They will share their insights and stimulate the discussion about the barriers on widespread adoption of 3D Printed medical devices.
During the afternoon, there will be round table discussions, involving all participants of the workshop in order to collaboratively develop the industry road mapping and further deal with barriers of widespread adoption of 3D Printed medical devices.